The Challenges for the US of Regulating Compliance and Quality on a Global Scale
This article was originally published in SRA
Executive Summary
Bob Rhoadesdiscusses the problems faced by US regulators and industry in ensuring the safety of imported devices and device components manufactured overseas.
You may also be interested in...
Biocon Biologics Refreshes Management
Biocon has made two key appointments to the management team of Biocon Biologics following a recent change in CEO for the biosimilars business.
Optibac Launches Natural Children’s Probiotic Immunity Supplement In Sustainable Pack
The UK's Optibac responds to sustainability and naturals trends with an all-in-one immunity and gut health food supplement especially designed for children.
India To Scrap Intellectual Property Appellate Board: Should Pharma Worry?
Legal experts tell the Pink Sheet why India’s plans to abolish the Intellectual Property Appellate Board and shift its powers to courts may be problematic for stakeholders, including those pursuing infringement charges. The transition could mean a significant burden on courts both in terms of capability and capacity, and IPR cases will now conflate into all other pending commercial matters, some experts said, though others cheered the proposed change.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: